Autoantigen microarrays for multiplex characterization of autoantibody responses

[1]  Lawrence Steinman,et al.  Proteomics technologies for the study of autoimmune disease. , 2002, Arthritis and rheumatism.

[2]  P. Fontoura,et al.  Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway. , 2001, Immunity.

[3]  P. Brown,et al.  Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions , 2001, Genome Biology.

[4]  S. Schreiber,et al.  Printing proteins as microarrays for high-throughput function determination. , 2000, Science.

[5]  Dieter Stoll,et al.  A microarray enzyme‐linked immunosorbent assay for autoimmune diagnostics , 2000, Electrophoresis.

[6]  J. Gabriel,et al.  Molecular and Structural Properties of Three Autoimmune IgG Monoclonal Antibodies to Histone H2B* , 2000, The Journal of Biological Chemistry.

[7]  J. Kirby,et al.  Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis , 2000, Immunological reviews.

[8]  P. Anderson,et al.  Death, autoantigen modifications, and tolerance , 2000, Arthritis research.

[9]  L. Lu,et al.  Major peptide autoepitopes for nucleosome-specific T cells of human lupus. , 1999, The Journal of clinical investigation.

[10]  G. Pruijn,et al.  Intracellular localization and nucleocytoplasmic transport of Ro RNP components. , 1997, European journal of cell biology.

[11]  P. Schur,et al.  Proteins Phosphorylated during Stress-induced Apoptosis Are Common Targets for Autoantibody Production in Patients with Systemic Lupus Erythematosus , 1997, The Journal of experimental medicine.

[12]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[13]  L. Steinman.  A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  U. Utz,et al.  Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein , 1996, Nature.

[15]  L. Steinman,et al.  Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Tan,et al.  Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .

[17]  E. Tan,et al.  Autoantibodies in the diagnosis of systemic rheumatic diseases. , 1995, Seminars in arthritis and rheumatism.

[18]  J. Goverman,et al.  T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. , 1994, Science.

[19]  I. Maurer-Fogy,et al.  Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. , 1992, The Journal of clinical investigation.

[20]  S. P. Fodor,et al.  Light-directed, spatially addressable parallel chemical synthesis. , 1991, Science.

[21]  R. Ekins,et al.  Multi-analyte immunoassay. , 1989, Journal of pharmaceutical and biomedical analysis.